Showing results (41-50 of 68) with videos related to
Sort By:
Pageof 7
International Journal of Hematology|June 15, 2014
Combination of bortezomib, thalidomide, and dexamethasone (VTD) as a consolidation therapy after autologous stem cell transplantation for symptomatic multiple myeloma in Japanese patientsShuichiro Takashima, Toshihiro Miyamoto, Masanori Kadowaki, et al.Internal Medicine (Tokyo, Japan)|June 17, 2014
The use of oral beclomethasone dipropionate in the treatment of gastrointestinal graft-versus-host disease: the experience of the Fukuoka blood and marrow transplantation (BMT) groupShuichiro Takashima, Tetsuya Eto, Motoaki Shiratsuchi, et al.European Journal of Haematology|March 30, 2023
IKZF1plus alterations are not associated with outcomes in Philadelphia-positive acute lymphoblastic leukemia patients enrolled in the FBMTG ALL/MRD2008 trialYoshikiyo Ito, Hidetoshi Ozawa, Tetsuya Eto, et al.Oncology Letters|January 2, 2016
Successful combination chemotherapy for metastatic inflammatory myofibroblastic tumor: A case reportKyoko Inadomi, Hozumi Kumagai, Kotoe Takayoshi, et al.The Journal of Biological Chemistry|January 25, 2005
Signal transducers and activators of transcription 3 augments the transcriptional activity of CCAAT/enhancer-binding protein alpha in granulocyte colony-stimulating factor signaling pathwayAkihiko Numata, Kazuya Shimoda, Kenjiro Kamezaki, et al.Blood|December 13, 2012
Quantitation of hematogones at the time of engraftment is a useful prognostic indicator in allogeneic hematopoietic stem cell transplantationTakahiro Shima, Toshihiro Miyamoto, Yoshikane Kikushige, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Cutting edge: tyk2 is required for the induction and nuclear translocation of Daxx which regulates IFN-alpha-induced suppression of B lymphocyte formationKazuya Shimoda, Kenjirou Kamesaki, Akihiko Numata, et al.International Journal of Hematology|January 3, 2024
Characteristics and prognosis of patients with COVID-19 and hematological diseases in Japan: a cross-sectional studyDaisuke Minakata, Tomoyuki Uchida, Aya Nakano, et al.Blood|March 6, 2002
Partial impairment of interleukin-12 (IL-12) and IL-18 signaling in Tyk2-deficient miceKazuya Shimoda, Hiroko Tsutsui, Kenichi Aoki, et al.Experimental Hematology|December 10, 2003
Limitin, an interferon-like cytokine, transduces inhibitory signals on B-cell growth through activation of Tyk2, but not Stat1, followed by induction and nuclear translocation of DaxxKenichi Aoki, Kazuya Shimoda, Kenji Oritani, et al.Pageof 7